![]() YSOPIA Bioscience YSOPIA Bioscience (formerly known as LNC Therapeutics) is a biotech company specializing in gut microbiome-based drug discovery. | ![]() Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. | ![]() Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. | |||
Founding Date | Founding Date 2010 | Founding Date 2010 | Founding Date 2022 | Founding Date 2009 | Founding Date 2017 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Boston, US | Locations Bordeaux, FR HQ | Locations Daytona Beach, US HQ | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB | Locations Carlsbad, US HQ |
Employees | Employees 3 | Employees 3 | Employees 1 | Employees 3716% decrease | Employees 54 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 18.4 m | Valuation ($) 131.4 m | Valuation ($) 313.1 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income N/A | Net income (kr58m) (FY, 2025) | Net income ($69.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 32.9m | Total funding raised $ 12.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 45m |

YSOPIA Bioscience (formerly known as LNC Therapeutics) is a biotech company specializing in gut microbiome-based drug discovery.
View company
Cadrenal Therapeutics is a clinical-stage biopharmaceutical company.
View company
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
View company
Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
View company